The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s brain-implant ...

The U.S. Securities and Exchange Commission (SEC) has pushed back a deadline for Elon Musk to respond to its offer to resolve ...

The Securities and Exchange Commission is preparing “numerous counts” against Elon Musk, according to a letter from his lawyer that Musk posted to X. It ...

The SEC has not released the letter. Nor would it comment on it or confirm whether it has issued such a demand to Musk.

Elon Musk renewed his longstanding feud with the Securities and Exchange Commission on Thursday by posting a letter that said ...

The U.S. Securities and Exchange Commission (SEC) this week has reopened an investigation into Elon Musk's brain-chip startup ...

Elon Musk's brain-chip implant startup Neuralink faces a new SEC probe, according to a letter from his lawyer he posted on X.

The Securities and Exchange Commission has issued a settlement demand to Tesla (TSLA) CEO Elon Musk and reopened an ...

Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implantable, wireless brain-computer interface (BCI).

Neuralink is therefore launching a new feasibility trial, aimed at extending control of the brain-computer interface using the N1 implant to an experimental assistive robotic arm.

Tesla Inc. TSLA has introduced a major enhancement to its humanoid robot, Optimus, featuring new hands. What Happened: This announcement aligns with Neuralink‘s recent FDA approval for its ...